RELATED CONTENT
NEWS
- Genmab and GSK file for Japanese approval of ofatumumab in CLL
- US judgement in anti-CD20 Mab suit favours GSK's Arzerra: Genentech/Biogen to appeal
- CHMP OKs Cell Therapeutics' pixantrone, but reserves view on use after rituximab
- New data strengthen profile for Pharmacyclics' novel blood cancer drug
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

